On May 2, the Valve and Structural Heart Center at Oklahoma Heart Institute (OHI) celebrated the 10-year anniversary of the first transcatheter aortic valve replacement (TAVR) in Tulsa.
TAVR is a minimally invasive treatment option for patients with narrowing of the aortic valve. When untreated, aortic stenosis results in disabling heart failure symptoms and shortened lifespan. Compared to open heart surgery, multiple studies have shown TAVR is more effective and safer, with lower risk of death, stroke and bleeding, as well as shorter hospital stays and a quicker return to normal... Read More »